Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Total Current Liabilities (2021 - 2026)

Zymeworks (ZYME) posted Total Current Liabilities of $35.6 million for Q1 2026, down 15.76% sequentially from $42.3 million in Q4 2025, and down 45.24% YoY from $65.1 million in Q1 2025.

Analysis

Zymeworks (ZYME) Total Current Liabilities (2021 - 2026) Analysis & Trends

Zymeworks has reported Total Current Liabilities for 6 years, with the latest figure at $35.6 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 45.24% year-over-year to $35.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.6 million (down 45.24% YoY) and the FY2025 annual result came in at $42.3 million, down 52.07% from the prior year.
  • Total Current Liabilities slipped to $35.6 million in Q1 2026 per ZYME's latest filing, from $42.3 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $95.6 million in Q4 2022 and troughed at $35.6 million in Q1 2026.
  • A 5-year average of $63.3 million and a median of $57.7 million in 2022 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 58.34% in 2024, then tumbled 52.07% in 2025.
  • Over 5 years, Total Current Liabilities stood at $95.6 million in 2022, then slumped by 41.69% to $55.8 million in 2023, then jumped by 58.34% to $88.3 million in 2024, then slumped by 52.07% to $42.3 million in 2025, then fell by 15.76% to $35.6 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $35.6 million, $42.3 million, and $42.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Zymeworks 2.13 Bn 1.86 Bn - 47.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.24 Mn
Mar 31, 2026 35.65 Mn
Dec 31, 2025 42.32 Mn
Sep 30, 2025 42.04 Mn
Jun 30, 2025 38.50 Mn
Mar 31, 2025 65.10 Mn
Dec 31, 2024 88.29 Mn
Sep 30, 2024 83.91 Mn
Jun 30, 2024 54.71 Mn
Mar 31, 2024 56.89 Mn
Dec 31, 2023 55.76 Mn
Sep 30, 2023 72.85 Mn
Jun 30, 2023 93.55 Mn
Mar 31, 2023 67.32 Mn
Dec 31, 2022 95.63 Mn
Sep 30, 2022 57.71 Mn
Dec 31, 2021 71.85 Mn